Canada Life’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $42K | Hold |
750
| – | – | ﹤0.01% | 1774 |
|
|
2025
Q4 | $36K | Hold |
750
| – | – | ﹤0.01% | 1813 |
|
|
2025
Q3 | $17K | Hold |
750
| – | – | ﹤0.01% | 1896 |
|
|
2025
Q2 | $17K | Hold |
750
| – | – | ﹤0.01% | 1915 |
|
|
2025
Q1 | $14K | Hold |
750
| – | – | ﹤0.01% | 1966 |
|
|
2024
Q4 | $10K | Hold |
750
| – | – | ﹤0.01% | 2013 |
|
|
2024
Q3 | $25K | Hold |
750
| – | – | ﹤0.01% | 2003 |
|
|
2024
Q2 | $19K | Hold |
750
| – | – | ﹤0.01% | 2034 |
|
|
2024
Q1 | $17K | Hold |
750
| – | – | ﹤0.01% | 2099 |
|
|
2023
Q4 | $16K | Hold |
750
| – | – | ﹤0.01% | 2134 |
|
|
2023
Q3 | $13K | Hold |
750
| – | – | ﹤0.01% | 2187 |
|
|
2023
Q2 | $15K | Hold |
750
| – | – | ﹤0.01% | 2200 |
|
|
2023
Q1 | $16K | Hold |
750
| – | – | ﹤0.01% | 2242 |
|
|
2022
Q4 | $23K | Hold |
750
| – | – | ﹤0.01% | 2226 |
|
|
2022
Q3 | $19K | Hold |
750
| – | – | ﹤0.01% | 2268 |
|
|
2022
Q2 | $15K | Hold |
750
| – | – | ﹤0.01% | 2312 |
|
|
2022
Q1 | $20K | Hold |
750
| – | – | ﹤0.01% | 2345 |
|
|
2021
Q4 | $26K | Hold |
750
| – | – | ﹤0.01% | 2324 |
|
|
2021
Q3 | $20K | Hold |
750
| – | – | ﹤0.01% | 2435 |
|
|
2021
Q2 | $19K | Sell |
750
-936
| -56% | -$22.4K | ﹤0.01% | 2485 |
|
|
2021
Q1 | $36K | Hold |
1,686
| – | – | ﹤0.01% | 2394 |
|
|
2020
Q4 | $36K | Hold |
1,686
| – | – | ﹤0.01% | 2389 |
|
|
2020
Q3 | $25K | Hold |
1,686
| – | – | ﹤0.01% | 2383 |
|
|
2020
Q2 | $37K | Hold |
1,686
| – | – | ﹤0.01% | 2321 |
|
|
2020
Q1 | $24K | Hold |
1,686
| – | – | ﹤0.01% | 2337 |
|
|
2019
Q4 | $27K | Buy |
+1,686
| New | +$39.9K | ﹤0.01% | 2434 |
|
|
2019
Q3 | – | Sell |
-3,177
| Closed | -$179K | – | 1171 |
|
|
2019
Q2 | $179K | Buy |
+3,177
| New | +$229K | ﹤0.01% | 2052 |
|
|
2019
Q1 | – | Sell |
-2,057
| Closed | -$127K | – | 2602 |
|
|
2018
Q4 | $127K | Hold |
2,057
| – | – | ﹤0.01% | 2063 |
|
|
2018
Q3 | $205K | Hold |
2,057
| – | – | ﹤0.01% | 1973 |
|
|
2018
Q2 | $146K | Buy |
2,057
+817
| +66% | +$68.5K | ﹤0.01% | 2071 |
|
|
2018
Q1 | $129K | Sell |
1,240
-954
| -43% | -$108K | ﹤0.01% | 2087 |
|
|
2017
Q4 | $220K | Buy |
2,194
+1,594
| +266% | +$117K | ﹤0.01% | 1945 |
|
|
2017
Q3 | $21K | Hold |
600
| – | – | ﹤0.01% | 2483 |
|
|
2017
Q2 | $14K | Buy |
+600
| New | +$15.1K | ﹤0.01% | 2522 |
|
Other funds holding ANAB
EC
TCM
AAA
VCM
PAI
6CM
Canada Life's ANAB Position: Q1 2026 in Review
Canada Life held its AnaptysBio (ANAB) position steady in Q1 2026 at 750 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #1774.
Canada Life first reported a position in ANAB in Q2 2017 and has held it in 34 quarters since. The position peaked at $220K in Q4 2017. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.
- Canada Life held 750 shares of AnaptysBio worth $42K as of Q1 2026.
- Canada Life left its AnaptysBio share count unchanged in Q1 2026.
- AnaptysBio made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1774 holding.
- Canada Life first reported a position in AnaptysBio in Q2 2017 and has held it in 34 quarters since.
- Canada Life's AnaptysBio position peaked at $220K in Q4 2017.
- 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.